- Home
- BBIO vs HMY Comparison
BBIO vs HMY Comparison
Compare BBIO & HMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BBIO
- HMY
- Stock Information
- Founded
- BBIO 2015
- HMY 1950
- Country
- BBIO United States
- HMY South Africa
- Employees
- BBIO N/A
- HMY N/A
- Industry
- BBIO Biotechnology: Pharmaceutical Preparations
- HMY Precious Metals
- Sector
- BBIO Health Care
- HMY Basic Materials
- Exchange
- BBIO Nasdaq
- HMY Nasdaq
- Market Cap
- BBIO 8.0B
- HMY 8.9B
- IPO Year
- BBIO 2019
- HMY N/A
- Fundamental
- Price
- BBIO $45.12
- HMY $13.90
- Analyst Decision
- BBIO Strong Buy
- HMY Sell
- Analyst Count
- BBIO 14
- HMY 2
- Target Price
- BBIO $58.85
- HMY $6.60
- AVG Volume (30 Days)
- BBIO 3.3M
- HMY 5.2M
- Earning Date
- BBIO 07-31-2025
- HMY 01-01-0001
- Dividend Yield
- BBIO N/A
- HMY 1.00%
- EPS Growth
- BBIO N/A
- HMY 16.30
- EPS
- BBIO N/A
- HMY 0.88
- Revenue
- BBIO $127,415,000.00
- HMY $3,553,951,394.00
- Revenue This Year
- BBIO $102.05
- HMY $23.09
- Revenue Next Year
- BBIO $54.69
- HMY $14.74
- P/E Ratio
- BBIO N/A
- HMY $14.95
- Revenue Growth
- BBIO N/A
- HMY 16.84
- 52 Week Low
- BBIO $21.72
- HMY $7.97
- 52 Week High
- BBIO $45.48
- HMY $18.77
- Technical
- Relative Strength Index (RSI)
- BBIO 77.53
- HMY 36.89
- Support Level
- BBIO $39.65
- HMY $13.65
- Resistance Level
- BBIO $45.18
- HMY $14.84
- Average True Range (ATR)
- BBIO 1.49
- HMY 0.38
- MACD
- BBIO 0.54
- HMY -0.11
- Stochastic Oscillator
- BBIO 99.13
- HMY 2.14
About BBIO BridgeBio Pharma Inc.
BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis) , is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.
About HMY Harmony Gold Mining Company Limited
Harmony Gold Mining Co Ltd is a gold mining and exploration company having operations in South Africa and Papua New Guinea (PNG). Its projects include Bambanani, Joel, Masimong, Phakisa, Target 1, Tshepong, Unisel, Doornkop, and Kusasalethu. The group's segments are Tshepong Operations, Bambanani, Joel, Doornkop, Moab Khotsong, Hidden Valley, Target 1, Kusasalethu, Masimong, Unisel, and all other surface operations.